This compound is a pharmaceutical intermediate specifically used in the manufacturing of linezolid, an antibiotic. It is a structurally defined chemical with a morpholine ring and a fluorinated aromatic group, suitable for laboratory and industrial synthesis applications.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 174649-09-3
(R)-1-benzyl-2-methylpiperazine
pharmaceutical intermediate
3-BROMO-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE
Pharmaceutical intermediate for research
3-(Bromomethyl)-7-chlorobenzo[b]thiophene
Pharmaceutical intermediate
4(3H)-Quinazolinone, 7-bromo-6-chloro-
pharmaceutical intermediate
(5R)-3-(3-fluoro-4-morpholin-4-ylphenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one
pharmaceutical intermediate
(5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone
active pharmaceutical ingredient impurity
(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)ethanethioamide
pharmaceutical reference standard
Linézolide
active pharmaceutical ingredient
[(5R)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl methanesulfonate
UCVIKCGVGWBTTI-GFCCVEGCSA-N
CS(=O)(=O)OC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F